QuickView for negative regulation of protein serine/threonine kinase activity (biogroup)

1. Neuroblastoma SKNDZ cells overexpressing MIR-125-B2
2. L1000 CMAP - Motor neuron MNEU.E cells treated with small molecule perturbagens
3. Calu-3 lung adenocarcinoma cells infected with wildtype and mutant SARS virus
4. Adipose tissue, adipocytes and stromal-vascular pellet cells from multiple body regions
5. L1000 CMAP - Prostate cancer PC3.101 cells with CRISPR-targeted gene knockouts

There were no matches for negative regulation of protein serine/threonine kinase activity

1. Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic …
2. Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced …
3. Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ER…
4. A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neuro…
5. Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML)